Gibson Christopher Insider Trading -- Recent SEC Form 4 Transactions

Gibson Christopher (CIK 1856369) reported 73 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy RXRX (40,000 shares), Sell RXRX (40,000 shares), Sell RXRX (22,821 shares), Buy RXRX (60,000 shares), Sell RXRX (40,000 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-06-05RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorBuy40,000$0
2026-06-05RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell40,000$144,800
2026-05-19RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell22,821$69,376
2026-05-08RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorBuy60,000$0
2026-05-08RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell40,000$134,800
2026-05-08RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell20,000$0
2026-04-24RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorBuy40,000$0
2026-04-24RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell40,000$144,400
2026-04-10PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)DirectorBuy57,473$0
2026-04-08RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorBuy40,000$0
2026-04-08RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell40,000$124,000
2026-03-25RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell40,000$130,000
2026-03-25RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorBuy40,000$0
2026-03-11RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorBuy20,000$0
2026-03-11RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell20,000$0
2026-03-05PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)DirectorBuy53,913$0
2026-02-19RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell27,265$95,155
2026-02-19RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorBuy40,000$0
2026-02-19RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell40,000$138,400
2026-02-06RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorBuy40,000$0
2026-02-06RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell40,000$164,800
2026-02-06RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorBuy30,346$0
2026-02-06RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell10,364$36,896
2026-01-22RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorBuy40,000$0
2026-01-22RECURSION PHARMACEUTICALS, INC. (RXRX)DirectorSell40,000$178,800

Source: SEC Form 4 filings · as of 2026-06-05